Editas Medicine, Inc.
Editas Medicine, Inc. (EDIT) has a dated narrative snapshot, but its priced-in model claim is temporarily suppressed because the model-solve record is unavailable or has changed.
198 institutional managers reported holding EDIT in 13F filings for the quarter ended 2026-03-31. Together they hold about 51% of the company; the top 10 hold 35%. 29 opened new positions that quarter. Held by BlackRock, Vanguard Group, Renaissance Technologies, among others. On the short side, 18.4M shares were sold short as of the 2026-06-15 count, about 19% of shares outstanding (7.7 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
EDIT's share count grew 44.2% over the past five years. It pays no dividend.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at EDIT over the trailing three years: 2024: 1 buy totaling $254k. 5 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
EDIT's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-03 | +7.6% | -23.0% |
| 2023-11-04 | +18.2% | +9.4% |
| 2024-02-29 | +13.5% | -44.1% |
| 2024-05-09 | -2.1% | -1.6% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
EDIT's latest 8-K filings: 2026-06-18 (items 5.07); 2026-05-26 (items 1.01, 8.01, 9.01); 2026-05-26 (items 8.01); 2026-05-26 (items 7.01, 8.01, 9.01); 2026-05-14 (items 7.01, 8.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.